The intraportal lymphoid nodule and its environment in... : Hepatology (original) (raw)

Original Articles: PDF Only

The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study

Mosnier, Jean-François M.D.*, 1; Degott, Claude1; Marcellin, Patrick2, 3; Hénin, Dominique1; Erlincer, Serge2, 3; Benhamou, Jean-Pierre2, 3

1_Service d'Anatomie et de Cytologie Pathologiques, Hôpital Beaujon, F-92118 Clichy, France_

2_Service d'Hépatologie, Hôpital Beaujon, F-92118 Clichy, France_

3_Unité de Recherches de Physiopathologie Hépatique (INSERM U24), Hôpital Beaujon, F-92118 Clichy, France_

*Address reprint requests to: Service d'Anatomie et de Cytologie Pathologiques, Hôpital Beaujon, 100 Boulevard du Général Leclerc, F-92118 Clichy, France

Received May 13, 1992; accepted October 12, 1992; previously published online December 05, 2005

Abstract

Intraportal lymphoid nodules have been observed in liver biopsy specimens from patients with autoimmune liver disease and chronic active hepatitis C. They are characterized by a nodular lymphocyte aggregate with a germinal center. The purpose of this in situ immunophenotyping study was to determine immunohistochemically the phenotype of immunocompetent cells in and around intraportal lymphoid nodules in patients with chronic hepatitis C. For comparison, we also examined lymphoid nodules in patients with autoimmune liver disease. Liver biopsy specimens from 13 unselected patients with CAH and hepatitis C antibodies and from 7 unselected patients with autoimmune liver disease seen during the same period were studied. Sections of snap-frozen specimens were immunostained with monoclonal antibodies directed against different subsets of T cells, B cells, follicular dendritic cells and macrophages. Intraportal lymphoid nodules were observed in 11 of 13 patients with chronic hepatitis C. They appeared as lymphoid follicles with activated B cells in germinal centers surrounded by a follicular dendritic cell network. A mantle zone of B cells was present around the aggregate of activated B cells. A T-cell zone comprising CD4-positive helper T cells, CD8-positive suppressor/cytotoxic T cells and a few CD25-positive activated T cells expressing interleukin-2 receptor was seen at the periphery of the nodules. Human leukocyte antigen DR was expressed by B cells and by T cells, indicating that T cells were activated. The immunocompetent cells observed in piecemeal necrosis were predominantly CD4 helper T cells, whereas those seen in the lobule were predominantly CD8 suppressor/cytotoxic T cells. Some polytypic plasma cells were present in piecemeal necrosis. Intraportal lymphoid nodules were also observed in one patient with type 1 autoimmune chronic hepatitis and in one patient with primary sclerosing cholangitis. These nodules had a pattern indistinguishable from that observed in the patients with chronic hepatitis C. Similarly, immunocompetent cells of piecemeal necrosis and liver lobule shared a similar phenotype. We conclude that intraportal lymphoid nodules seen in chronic hepatitis C may be true functional lymphoid follicles, which induce stimulation of effector T cells and B cells. The characteristics of the nodules, their similarity with those observed in autoimmune liver disease and the presence of autoantibodies suggest an immune mechanism in the liver injury of chronic hepatitis C virus infection. (Hepatology 1993;17:366-371.)